Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
About this episode
Dr. Natalie Vokes discusses the role of circulating tumor DNA assays in lung cancer management.
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications here .
More episodes of Oncology Today with Dr Neil Love
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
- HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.